Paclitaxel-induced exosome circBACH1 regulates BC cell stemness and migration by sponging miR-217 to upregulate G3BP expression, which provides a new therapeutic target for paclitaxel resistance and BC progression through the circBACH1/miR-217/G3BP2 axis. This evidence concerns the gene G3BP2 and breast cancer.